TEN 20 M 1000 10 TABLET

Teneligliptin is an oral anti-diabetic drug that belongs to the class of dipeptidyl peptidase-4 (DPP-4) inhibitors. It is used in the treatment of type 2 diabetes mellitus, a chronic condition characterized by high blood sugar levels due to the body's inability to produce enough insulin or effectively use the insulin it produces. The medication works by increasing the amount of insulin released by the pancreas and decreasing the amount of glucose released by the liver. Teneligliptin is available in tablet form, with each tablet containing 20mg of the active ingredient. It is usually taken once a day, with or without food, and is often prescribed in combination with other anti-diabetic medications or lifestyle modifications such as diet and exercise. The composition of TEN 20 M 1000 10 TABLET is Teneligliptin (20mg), which is the primary active ingredient responsible for its therapeutic effects. The medication has a molecular formula of C22H30N6O5S and a molecular weight of 426.57 g/mol. It is a white to off-white crystalline powder that is soluble in water and has a melting point of 153-155°C. Teneligliptin is manufactured by various pharmaceutical companies and is available under different brand names. The medication has been shown to be effective in reducing hemoglobin A1c (HbA1c) levels, a measure of average blood glucose control over time, and has a relatively low risk of hypoglycemia compared to other anti-diabetic medications.

Teneligliptin is primarily used in the treatment of type 2 diabetes mellitus, a condition characterized by high blood sugar levels due to insulin resistance or impaired insulin secretion. The medication is often prescribed in combination with other anti-diabetic medications, such as metformin or sulfonylureas, to achieve better blood glucose control. Teneligliptin can be used as monotherapy or in combination with other medications, and its use is recommended for patients who are unable to achieve adequate blood glucose control with diet and exercise alone. The medication has been shown to be effective in reducing HbA1c levels and has a relatively low risk of hypoglycemia compared to other anti-diabetic medications. Teneligliptin can also be used in patients with renal impairment, although the dose may need to be adjusted based on the severity of the impairment. The medication has been shown to be effective in reducing HbA1c levels in patients with mild to moderate renal impairment, and its use is recommended in these patients. However, the medication should be used with caution in patients with severe renal impairment, as it may increase the risk of adverse effects such as hypoglycemia and renal failure. Teneligliptin is not recommended for use in patients with type 1 diabetes mellitus or diabetic ketoacidosis, as it is not effective in these conditions and may worsen the underlying disease.

The primary benefit of Teneligliptin is its ability to improve blood glucose control in patients with type 2 diabetes mellitus. The medication has been shown to reduce HbA1c levels, a measure of average blood glucose control over time, and has a relatively low risk of hypoglycemia compared to other anti-diabetic medications. Teneligliptin also has a low risk of weight gain, a common side effect of many anti-diabetic medications, and may even promote weight loss in some patients. The medication has been shown to be effective in reducing blood pressure and lipid levels, which can help to reduce the risk of cardiovascular disease in patients with type 2 diabetes. Teneligliptin is also convenient to use, as it is available in a once-daily dosage form and can be taken with or without food. The medication has a relatively low risk of adverse effects, and most patients are able to tolerate it well. Teneligliptin is also available at a relatively low cost compared to other anti-diabetic medications, which can make it a more affordable option for patients who require long-term treatment. The medication has been shown to be effective in improving quality of life in patients with type 2 diabetes, and its use is recommended for patients who are unable to achieve adequate blood glucose control with diet and exercise alone.

The most common side effects of Teneligliptin include headache, dizziness, and nausea. These side effects are usually mild and temporary, and may resolve on their own within a few days of starting treatment. Other common side effects of Teneligliptin include diarrhea, abdominal pain, and vomiting. These side effects are usually mild and may be managed with supportive care such as rest and hydration. In rare cases, Teneligliptin may cause more serious side effects such as hypoglycemia, renal failure, and pancreatitis. Teneligliptin may also increase the risk of adverse effects such as urinary tract infections and female genital infections. These side effects are usually mild and may be managed with supportive care such as antibiotics and antifungal medications. In rare cases, Teneligliptin may cause more serious side effects such as Stevens-Johnson syndrome and toxic epidermal necrolysis, which are life-threatening skin conditions that require immediate medical attention. Patients who experience any side effects while taking Teneligliptin should contact their healthcare provider promptly, as some side effects may require medical attention.

Teneligliptin is usually taken once a day, with or without food. The medication should be taken at the same time every day, and patients should try to establish a regular routine to ensure that they do not miss any doses. The dose of Teneligliptin may need to be adjusted based on the patient's response to treatment, and patients should follow the dosage instructions provided by their healthcare provider. Patients who miss a dose of Teneligliptin should take it as soon as they remember, unless it is almost time for the next dose. Patients who are taking Teneligliptin should monitor their blood glucose levels regularly, as the medication may increase the risk of hypoglycemia. Patients should also monitor their kidney function regularly, as Teneligliptin may increase the risk of renal impairment. Patients who experience any side effects while taking Teneligliptin should contact their healthcare provider promptly, as some side effects may require medical attention. Patients should not stop taking Teneligliptin without consulting their healthcare provider, as this may worsen their condition. Patients should also inform their healthcare provider about any other medications they are taking, as Teneligliptin may interact with other medications.

Teneligliptin works by increasing the amount of insulin released by the pancreas and decreasing the amount of glucose released by the liver. The medication inhibits the activity of dipeptidyl peptidase-4 (DPP-4), an enzyme that breaks down incretin hormones such as glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). Incretin hormones play a crucial role in regulating blood glucose levels, and their breakdown by DPP-4 can lead to a decrease in insulin secretion and an increase in glucose production. By inhibiting the activity of DPP-4, Teneligliptin increases the levels of incretin hormones in the body, which in turn stimulates the release of insulin from the pancreas and decreases the release of glucose from the liver. This leads to a decrease in blood glucose levels and an improvement in insulin sensitivity. Teneligliptin also has a low risk of hypoglycemia, as it only increases insulin secretion in response to high blood glucose levels. The medication has been shown to be effective in reducing HbA1c levels and improving blood glucose control in patients with type 2 diabetes mellitus.

Patients who are taking Teneligliptin should be aware of the potential risks and precautions associated with its use. The medication may increase the risk of hypoglycemia, particularly when used in combination with other anti-diabetic medications. Patients should monitor their blood glucose levels regularly and adjust their dosage accordingly. Teneligliptin may also increase the risk of renal impairment, particularly in patients with pre-existing kidney disease. Patients should monitor their kidney function regularly and adjust their dosage accordingly. Patients who are taking Teneligliptin should also be aware of the potential for drug interactions. The medication may interact with other medications such as warfarin, digoxin, and statins, and patients should inform their healthcare provider about any other medications they are taking. Patients who are pregnant or breastfeeding should use Teneligliptin with caution, as its safety in these populations has not been established. Patients who have a history of pancreatitis or pancreatic cancer should use Teneligliptin with caution, as the medication may increase the risk of these conditions.

Patients who are taking Teneligliptin should be cautious when driving or operating heavy machinery, as the medication may cause dizziness and hypoglycemia. Patients should also be cautious when consuming alcohol, as it may increase the risk of hypoglycemia and other adverse effects. Teneligliptin may also increase the risk of allergic reactions, particularly in patients who have a history of allergies. Patients should be aware of the signs and symptoms of allergic reactions, such as rash, itching, and difficulty breathing, and should seek medical attention promptly if they experience any of these symptoms. Patients who are taking Teneligliptin should also be cautious when traveling, as the medication may be affected by changes in temperature and humidity. Patients should store the medication in a cool, dry place and protect it from light. Patients should also be aware of the potential for medication errors, particularly when taking multiple medications. Patients should use a pill box or other medication reminder to ensure that they take their medications correctly and do not miss any doses. Patients should also inform their healthcare provider about any changes in their medical condition or medications, as this may affect the safety and efficacy of Teneligliptin.